Bacterial Antigens
Creative Biolabs offers a comprehensive range of high-quality Bacterial Antigens to robustly support clients' vaccine research. Our bacterial antigen portfolio covers a diverse array of pathogens, including Aeromonas, Bacillus, Escherichia Coli, Helicobacter Pylori, Streptococcus Pneumoniae, and many more. These antigens are meticulously developed to exhibit excellent sensitivity and specificity, making them ideal for use as immunogens in vaccine development and for serological diagnostic tests. With sufficient inventory maintained, we ensure fast worldwide delivery, and quantity discounts are available to meet different research scales.
Beyond catalog products, our advanced protein expression services further strengthen vaccine research support. Leveraging well-established systems like E. coli, yeast, and mammalian cells, we provide end-to-end solutions from gene optimization and vector construction to large-scale expression and purification. We conduct small-scale feasibility tests upfront to minimize risks and costs, ensuring each project progresses efficiently. Whether for early-stage research or large-scale production, our bacterial antigens and integrated services are tailored to accelerate clients' vaccine development milestones with reliability and professionalism.
Don’t miss the opportunity to collaborate with experts who prioritize your project’s efficiency and success. Reach out without delay to discuss your specific needs and receive a personalized quote, ensuring your research gains a competitive edge with our high-quality products and dedicated support!
| CAT | Product Name | Source | Product Overview | Target | Type | Datasheet | Size | Price |
|---|---|---|---|---|---|---|---|---|
| VAng-0573Lsx | Recombinant Treponema Pallidum p47 Protein [His] (E. coli) | E. coli. | Treponema Pallidum p47, mosaic of immunodominant regions, recombinant protein from E. coli, MW 45 kDa, 8.00 mg/mL. | Treponema Pallidum | Bacterial Antigens |  |
1 mg | Inquiry |
| VAng-0574Lsx | Recombinant Treponema Pallidum p15 Protein [His] (E. coli) | E. coli. | Treponema Pallidum p15 (Syphilis), recombinant protein from E. coli, MW 19 kDa, 5.40 mg/mL. | Treponema Pallidum | Bacterial Antigens | |
1 mg | Inquiry |
| VAng-0575Lsx | Recombinant Treponema Pallidum p41 Protein | E. coli. | Treponema Pallidum p41 (Syphilis), recombinant protein from E. coli, fused with Beta-galactosidase (114 kDa) at the N-terminus, MW 153 kDa, 9.00 mg/mL. | Treponema Pallidum | Bacterial Antigens | |
1 mg | Inquiry |
| VAng-0576Lsx | Recombinant Treponema Pallidum p17 Protein (11.00 mg/mL) | E. coli. | Treponema Pallidum p17 (Syphilis), recombinant protein from E. coli, fused with Beta-galactosidase (114 kDa) at the N-terminus, MW 137 kDa, 11.00 mg/mL. | Treponema Pallidum | Bacterial Antigens | |
1 mg | Inquiry |
| VAng-0577Lsx | Recombinant Treponema Pallidum p17 Protein [GST] | E. coli. | Treponema Pallidum p17 (Syphilis), recombinant protein from E. coli, fused with Beta-galactosidase (114 kDa) at the N-terminus, 1.11 mg/mL. | Treponema Pallidum | Bacterial Antigens | |
1 mg | Inquiry |
| VAng-0578Lsx | Recombinant Treponema Pallidum TmpA Protein [His] | E. coli. | Treponema Pallidum Treponemal Membrane Protein A (TmpA), recombinant protein from E. coli, MW 42.9 kDa. | Treponema Pallidum | Bacterial Antigens | |
1 mg | Inquiry |
| VAng-0579Lsx | Recombinant Treponema Pallidum TmpA Protein (Full Length) [His] | E. coli. | Treponema Pallidum Treponemal Membrane Protein A (TmpA) Full Length, recombinant protein from E. coli, fused with Beta-galactosidase (114 kDa) at the N-terminus, MW 42 kDa, 1.00 mg/mL. | Treponema Pallidum | Bacterial Antigens | |
100 µg | Inquiry |
| VAng-0581Lsx | Recombinant Treponema Pallidum TmpA Protein (aa 23-41, 288-325) [GST] | E. coli. | Treponema Pallidum Treponemal Membrane Protein A (TmpA), recombinant protein from E. coli, MW 32 kDa, 10.00 mg/mL. | Treponema Pallidum | Bacterial Antigens | |
1 mg | Inquiry |
| VAng-4471Lsx | Recombinant Borrelia Garinii OspC Protein | E. coli. | Borrelia Garinii OspC, recombinant protein from E. coli. | Borrelia | Bacterial Antigens | |
5 µg | Inquiry |
All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.
